564 related articles for article (PubMed ID: 24346753)
1. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
Huang MC; Chen CH; Pan CH; Lin SK
J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
[TBL] [Abstract][Full Text] [Related]
2. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
3. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial.
Martinotti G; di Nicola M; Frustaci A; Romanelli R; Tedeschi D; Guglielmo R; Guerriero L; Bruschi A; De Filippis R; Pozzi G; Di Giannantonio M; Bria P; Janiri L
Addiction; 2010 Feb; 105(2):288-99. PubMed ID: 20078487
[TBL] [Abstract][Full Text] [Related]
4. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
5. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
Myrick H; Malcolm R; Randall PK; Boyle E; Anton RF; Becker HC; Randall CL
Alcohol Clin Exp Res; 2009 Sep; 33(9):1582-8. PubMed ID: 19485969
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
[TBL] [Abstract][Full Text] [Related]
7. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal.
Mueller SW; Preslaski CR; Kiser TH; Fish DN; Lavelle JC; Malkoski SP; MacLaren R
Crit Care Med; 2014 May; 42(5):1131-9. PubMed ID: 24351375
[TBL] [Abstract][Full Text] [Related]
9. Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam.
Krupitsky EM; Rudenko AA; Burakov AM; Slavina TY; Grinenko AA; Pittman B; Gueorguieva R; Petrakis IL; Zvartau EE; Krystal JH
Alcohol Clin Exp Res; 2007 Apr; 31(4):604-11. PubMed ID: 17374039
[TBL] [Abstract][Full Text] [Related]
10. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials.
Sang CN; Booher S; Gilron I; Parada S; Max MB
Anesthesiology; 2002 May; 96(5):1053-61. PubMed ID: 11981142
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of fixed tapering dose regimen versus symptom-triggered regimen of lorazepam for alcohol detoxification.
Sachdeva A; Chandra M; Deshpande SN
Alcohol Alcohol; 2014; 49(3):287-91. PubMed ID: 24407777
[TBL] [Abstract][Full Text] [Related]
12. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
Malcolm R; Myrick LH; Veatch LM; Boyle E; Randall PK
J Clin Sleep Med; 2007 Feb; 3(1):24-32. PubMed ID: 17557449
[TBL] [Abstract][Full Text] [Related]
13. Dextromethorphan and quinidine combination for heroin detoxification.
Akerele E; Bisaga A; Sullivan MA; Garawi F; Comer SD; Thomas AA; Nunes EV; Kleber HD
Am J Addict; 2008; 17(3):176-80. PubMed ID: 18463993
[TBL] [Abstract][Full Text] [Related]
14. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome.
Di Nicola M; Martinotti G; Tedeschi D; Frustaci A; Mazza M; Sarchiapone M; Pozzi G; Bria P; Janiri L
Hum Psychopharmacol; 2010 Apr; 25(3):268-75. PubMed ID: 20373479
[TBL] [Abstract][Full Text] [Related]
17. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial.
Malcolm R; Myrick H; Roberts J; Wang W; Anton RF; Ballenger JC
J Gen Intern Med; 2002 May; 17(5):349-55. PubMed ID: 12047731
[TBL] [Abstract][Full Text] [Related]
18. Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial.
Melby K; Gråwe RW; Aamo TO; Salvesen Ø; Spigset O
Drug Alcohol Depend; 2019 Apr; 197():95-101. PubMed ID: 30784955
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: a double-blind, placebo-controlled trial.
Alho H; Methuen T; Paloheimo M; Strid N; Seppä K; Tiainen J; Salaspuro M; Roine R
Alcohol Clin Exp Res; 2002 Dec; 26(12):1816-22. PubMed ID: 12500105
[TBL] [Abstract][Full Text] [Related]
20. Intranasal oxytocin blocks alcohol withdrawal in human subjects.
Pedersen CA; Smedley KL; Leserman J; Jarskog LF; Rau SW; Kampov-Polevoi A; Casey RL; Fender T; Garbutt JC
Alcohol Clin Exp Res; 2013 Mar; 37(3):484-9. PubMed ID: 23025690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
